Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment
Nicole Kirchhammer, Marcel P. Trefny, Priska Auf der Maur, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 670
Closed Access | Times Cited: 114

Showing 1-25 of 114 citing articles:

The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
Karin E. de Visser, Johanna A. Joyce
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 374-403
Open Access | Times Cited: 1477
Nanomaterials in tumor immunotherapy: new strategies and challenges
Xudong Zhu, Shenglong Li
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 101
An Immunocompetent Hafnium Oxide-Based STING Nanoagonist for Cancer Radio-immunotherapy
Yuhua Cao, Shuaishuai Ding, Yunping Hu, et al.
ACS Nano (2024) Vol. 18, Iss. 5, pp. 4189-4204
Closed Access | Times Cited: 27
The role of RNA methylation in tumor immunity and its potential in immunotherapy
Yan Li, Haoer Jin, Qingling Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 26
Transformable Supramolecular Self‐Assembled Peptides for Cascade Self‐Enhanced Ferroptosis Primed Cancer Immunotherapy
He Wang, Di Jiao, Dexiang Feng, et al.
Advanced Materials (2024) Vol. 36, Iss. 21
Closed Access | Times Cited: 24
Cuproptosis: unveiling a new frontier in cancer biology and therapeutics
Ying Feng, Zhibo Yang, Jianpeng Wang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 18
Dual-targeting nanozyme combined with aPD-L1-based immunotherapy for combating cancer recurrence and metastasis
Lu Tang, Yuqi Cao, Yue Yin, et al.
Materials Today (2024) Vol. 73, pp. 79-95
Closed Access | Times Cited: 17
Targeting triple negative breast cancer stem cells using nanocarriers
Nagasen Dasari, Girijasankar Guntuku, Sai Kiran S. S. Pindiprolu
Discover Nano (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 17
Nanomaterials for mRNA‐based therapeutics: Challenges and opportunities
Defeng Li, Qisong Liu, Meifeng Yang, et al.
Bioengineering & Translational Medicine (2023) Vol. 8, Iss. 3
Open Access | Times Cited: 37
Ferroptosis and tumor immunotherapy: A promising combination therapy for tumors
Huazhong Cai, Yongfei Ren, Shuangwei Chen, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 33
Amplifying oxidation stress and T-cell activation by bioactive layered double hydroxide sonosensitizers for enhanced cancer immunotherapy
Jie Wu, Li Wang, Wei Tang, et al.
Materials Today (2023) Vol. 68, pp. 164-176
Closed Access | Times Cited: 27
Beyond Drug Delivery System: Immunomodulatory Layered Double Hydroxide Nanoadjuvants Take an Essential Step Forward in Cancer Immunotherapy
Chaojie Zhu, Jianping Jiang, Yingbo Jia, et al.
Accounts of Materials Research (2023) Vol. 4, Iss. 9, pp. 758-771
Closed Access | Times Cited: 27
The E3 ubiquitin ligases regulate PD-1/PD-L1 protein levels in tumor microenvironment to improve immunotherapy
Bo Hou, Ting Chen, He Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
68Ga-FAPI PET imaging monitors response to combined TGF-βR inhibition and immunotherapy in metastatic colorectal cancer
Ké Li, Wei Liu, Hang Yu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 4
Open Access | Times Cited: 11
The opportunities and challenges of using PD-1/PD-L1 inhibitors for leukemia treatment
Mengdan Xu, Shenglong Li
Cancer Letters (2024) Vol. 593, pp. 216969-216969
Closed Access | Times Cited: 11
Engagement of sialylated glycans with Siglec receptors on suppressive myeloid cells inhibits anticancer immunity via CCL2
Ronja Wieboldt, Michael T. Sandholzer, Emanuele Carlini, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 5, pp. 495-509
Open Access | Times Cited: 10
Reciprocal inhibition between TP63 and STAT1 regulates anti-tumor immune response through interferon-γ signaling in squamous cancer
Yuan Jiang, Yueyuan Zheng, Yuan‐Wei Zhang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Extracellular vesicles hybrid plasmid-loaded lipid nanovesicles for synergistic cancer immunotherapy
Qing Tong, Kexin Li, Fanwei Huang, et al.
Materials Today Bio (2023) Vol. 23, pp. 100845-100845
Open Access | Times Cited: 19
Anti‐angiogenic therapy enhances cancer immunotherapy: Mechanism and clinical application
Anqi Li, Jian‐Hong Fang
Deleted Journal (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 7
Recent Advances in Nanomodulators for Augmenting Cancer Immunotherapy in Cold Tumors: Insights from Drug Delivery to Drug‐Free Strategies
Lingxiao Zhang, Chaojie Zhu, Jing Zhao, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 18
Open Access | Times Cited: 7
Nanotechnology-based in situ cancer vaccines: Mechanisms, design, and recent advances
Gaoli Niu, Hong Wang, Yanhong Zhai, et al.
Nano Today (2024) Vol. 56, pp. 102286-102286
Closed Access | Times Cited: 7
Insights into therapeutic peptides in the cancer-immunity cycle: Update and challenges
Xiao-kun Zhang, Ye Wu, Jia-Yi Lin, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3818-3833
Open Access | Times Cited: 6
Personalized Nanovaccines Enhance Lymph Node Accumulation and Reprogram the Tumor Microenvironment for Improved Photodynamic Immunotherapy
Ruoning Wang, Jinge Li, Xiaohong Wang, et al.
Nano Letters (2024) Vol. 24, Iss. 24, pp. 7432-7442
Closed Access | Times Cited: 6
Engineered nano-aluminum adjuvant for cancer immunotherapy: Progress, challenges and opportunities towards preclinical/clinical application
Chong Gao, Jianping Jiang, Jing Zhao, et al.
Coordination Chemistry Reviews (2024) Vol. 519, pp. 216109-216109
Open Access | Times Cited: 6
Comprehensive characterization of tumor microenvironment in colorectal cancer via molecular analysis
Xiangkun Wu, Hong Yan, Mingxing Qiu, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top